TNFRSF9 and neoplasm: Taken together, our results then raise the intriguing notion that the reciprocal regulation of tumor TGF-β and 4-1BB costimulation may determine the efficacy of anti-4-1BB therapy in part through STAT3-mediated CD73 expression on effector T cells.